Sharepoint Solutions

WHITE PAPERS AND CASE STUDIES

• Six Strategies For Accelerating Approval For Cell And Gene Therapies

  As you advance through the evolving regulatory landscape for cell and gene therapies, review these six proven strategies to help sponsors reduce their risk of failure and expedite speed to market.

• Are You Leveraging All Of Your Clinical Data?

  To develop and execute a successful clinical strategy, trial sponsors must be able to rapidly acquire detailed data insights. Learn how you can better utilize your trial data and achieve greater insights.

• Enabling CDMOs To Focus On Core Priorities

  Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.

• IT Changes Implemented To Overcome Future Manufacturing Challenges

  Learn how Pfizer and Ferring improved their reporting and batch information management with Rockwell’s technology.

• CRO Leverages Partnership With Integrated Central IBC To Initiate Sites

  Discover how a CRO was able to reduce study startup timelines and deliver trial results to the sponsor quicker than expected.

• The Key To Accelerating RNA-LNP Drug Development

  Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.

• RNA: The Next Era In Therapeutic Development

  Review the unique set of challenges for RNA production that must be considered and solved to reach their full therapeutic potential.

• AqueoUS Vets Named A Manufacturing Partner For A Southern CA Water Treatment Facility

  In August 2018, Aqueous Vets was selected over existing industry incumbents to supply the Granular Activated Carbon Systems (GACS) for a Southern California Water Treatment Plant.

• Designing, Selecting, And Developing Bioconjugates For Clinical Success

  Accelerate the development of complex bioconjugates to unlock new possibilities for targeted therapies and advance the next generation of precision medicine.

• Project Orbis Drug Registration 2025

  Project Orbis helps streamline the review and approval of oncology medicinal products through international regulatory collaboration. Learn how this framework can accelerate your regulatory strategy.

• Improving Patient Health And Safety

  Engage an experienced CMC program management consultant to collaboratively develop and maintain a robust product development plan (PDP) with your team lead, cross-functional members, and vendors.

• Controlling Trace Impurities In Chemically Defined Media

  Discover a novel approach for manufacturing chemically defined media with precision control of trace impurities that utilizes innovative raw material analysis, data analytics, and a proprietary algorithm.